M. bovis uses several different serotyped fimbriae as virulence factors, consequently pharmaceutical companies have exploited this to create vaccines.
Several different serotyped fimbriae that M. bovis employs serve as virulence factors; consequently, pharmaceutical firms have harnessed this knowledge for vaccine creation.